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Timely linkage to care by newly-diagnosed HIV+ individuals remains a significant challenge
to achieving UNAIDS 90-90-90 goals. Current World Health Organization (WHO) guide-
lines recommend initiating anti-retroviral treatment (ART) regardless of CD4+ count, with
priority given to those with CD4+ <350 cells/μl. We evaluated the impact of not having a
day-of-diagnosis CD4+ count blood draw, as recommended by South African guidelines,
on time to linkage, using data from a prospective cohort study.
Methods
Individuals (N = 2773) were interviewed prior to HIV counseling and testing at three public
sector primary care clinics in the greater Durban area; 785 were newly-diagnosed and eligi-
ble for the cohort study; 459 (58.5%) joined and were followed for eight months with three
structured assessments. Linkage to care, defined as returning to clinic for CD4+ count
results, and day-of-diagnosis blood draw were self-reported.
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Results
Overall, 72.5% did not have a day-of-diagnosis CD4+ count blood draw, and 19.2% of
these never returned. Compared with a day-of-diagnosis blood draw, the adjusted hazard
ratio of linkage (AHRlinkage) associated with not having day-of-diagnosis blood draw was
0.66 (95%CI: 0.51, 0.85). By 4 months, 54.8% of those without day-of-diagnosis blood
draw vs. 75.2% with one were linked to care (chi-squared p = 0.004). Of those who deferred
blood draw, 48.3% cited clinic-related and 51.7% cited personal reasons. AHRlinkage was
0.60 (95%CI: 0.44, 0.82) for clinic-related and 0.53 (95%CI: 0.38, 0.75) for personal rea-
sons relative to having day-of-diagnosis blood draw.
Conclusions
Newly-diagnosed HIV+ individuals who did not undergo CD4+ count blood draw on the day
they were diagnosed—regardless of the reason for deferring—had delayed linkage to care
relative to those with same-day blood draw. To enhance prompt linkage to care even when
test and treat protocols are implemented, all diagnostic testing required before ART initia-
tion should be performed on the same day as HIV testing/diagnosis. This may require modi-
fying clinic procedures to enable overnight blood storage if same-day draws cannot be
performed, and providing additional counseling to encourage newly-diagnosed individuals
to complete day-of-diagnosis testing. Tracking HIV+ individuals via clinic registries should
commence immediately from diagnosis to reduce these early losses to care.
Introduction
In most low and middle income countries (LMIC) current practice is to stage individuals’ HIV
disease, either clinically or through CD4+ count, as a first step in care. In September 2015,
World Health Organization (WHO) guidelines were revised to recommend that all HIV+ indi-
viduals be placed immediately on antiretroviral therapy (ART) regardless of CD4+ cell count,
and that those with CD4+ count less than 350 cells/μl be prioritized for ART initiation [1].
This guidance draws from the findings of the START [2] and TEMPRANO [3] studies, both of
which demonstrated a substantial benefit of ART on HIV-related morbidity regardless of the
stage of disease at which treatment was initiated. Regardless of the newWHO guidelines, base-
line CD4+ count testing will likely continue in many LMIC, both (1) to prioritize individuals
for ART initiation when resources are limited, and (2) to determine need for opportunistic
infection prophylaxis, especially given that large proportions of individuals are diagnosed and/
or enrolled in care with very low CD4+ counts [4–6]. Earlier studies noted low completion
rates of this step [7–10], and one demonstrated that HIV+ individuals who were not staged by
WHO clinical guidelines on the same day as their HIV diagnosis were less likely to complete
ART eligibility assessment [10]. Point-of-care CD4+ count testing with provision of the test
results at the time of diagnosis has been shown to facilitate more rapid linkage to HIV care
[11–13] but remains beyond the capacity of many public sector clinics in LMIC.
During the first decade of ART roll-out in South Africa, treatment thresholds tended to lag
behind those recommended by WHO, but in recent years, guidelines generally have been in
line with those recommended by WHO [14,15]. During 2010–2013, the period relevant for this
study, South Africamoved from a treatment initiation threshold of less than 350 cells/μl only
for pregnant women and TB-co-infected adults to this threshold for all HIV+ adults. Notably,
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beginning in 2010, South African guidelines encouraged blood to be drawn for a CD4+ count
assay at the same clinic visit as the initial HIV diagnosis to encourage timely determination of
eligibility for ART [16]. The degree to which this policy was implemented, and its effect on
time until individuals are linked to care, are unknown.
In a prospective cohort study, ‘Pathways to Engagement in HIV Care for Newly-Diagnosed
South Africans’ (hereafter, Pathways to Care), we examined what proportion of individuals
had blood drawn for CD4+ count determination on the day of diagnosis, reasons for not doing
so on that day, and the relationship between not having a day-of-diagnosis blood draw and
time to linkage to care. The results of this analysis provide critical insights into how procedures
required for access to care and treatment might promote or delay linkage to those services.
Methods
The Pathways to Care cohort consisted of newly-diagnosedHIV+ women and men recruited
from three public sector primary healthcare clinics (PHC) located in greater Durban, including
two sites in urban areas and one in a rural area. KwaZulu-Natal, the province in which Durban
is situated, has the highest HIV prevalence in South Africa, with 17.4% (15.8–19.2) of the popu-
lation aged two years and older infected in 2012 [17]. All three clinics routinely provided a
range of primary healthcare services and ART treatment in addition to HIV counseling and
testing (HCT). Participants were recruited betweenNovember 2010 and May 2012, and were
followed for up to eight months after diagnosis to identify factors associated with time to link-
age to care.
Participants
Eligibility criteria included being aged 18 years or older, testing HIV+ on the day of recruit-
ment, not previously having been diagnosedHIV+, and willing to have HIV test results shared
with the study interviewer. We excluded individuals who did not anticipate residing in their
community for at least one year (to ensure high retention and data quality), were pregnant, did
not speak and understand English or isiZulu, or were observedby study staff to be cognitively
impaired. Pregnant women and those referred from antenatal care were excluded because they
represent a different population of newly-diagnosed individuals; their patterns of diagnosis,
referral, and care differ from those of men and non-pregnant women, and studying them
would have required a sufficient sample to make inferences around that group alone.
To recruit the cohort, all persons presenting to one of the three clinic sites for HIV testing
(or every second person if it was not possible to approach all on a given day) were invited to a
20-minute screening interviewprior to testing (Fig 1). The screening interview ascertained
study eligibility and potential psychosocial determinants of linkage to HIV care. After clinic
personnel conductedHCT, individuals who were HIV+ and/or had elevated symptoms of psy-
chological distress on the screening interview as determined by the Kessler-10 [18] were invited
to a 5-minute post-test interview, which ascertainedperceived barriers to care and interest in
ancillary service/support referrals. Distressed individuals were included in the post-test inter-
view so that the status of HIV+ individuals would not be revealed on account of their participa-
tion. After the post-test interview, HIV+ individuals were invited to join the cohort study.
Participants were reimbursed R40 and R15 (the approximate equivalent of US $5 and $2 at the
time) for the screening and post-test interviews, respectively.
Written informed consent was obtained prior to the screening interview;an additional writ-
ten informed consent was obtained prior to the baseline interview for the cohort study. All pro-
cedures were approved by the Institutional ReviewBoard of the NYS Psychiatric Institute/
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Fig 1. Participant flow for Pathways to Engagement in HIV Care for Newly-Diagnosed South Africans.
doi:10.1371/journal.pone.0162085.g001
Same-Day CD4+ Count Blood Draw and Linkage to Care
PLOS ONE | DOI:10.1371/journal.pone.0162085 October 5, 2016 4 / 16
Columbia University Department of Psychiatry and the Biomedical Research Ethics Commit-
tee of the University of KwaZulu-Natal.
Assessment and cohort follow-up
Cohort study participants underwent a structured interview at baseline, which was conducted
within 30 days of initial HIV diagnosis, and at four and eight months after diagnosis. Follow-
up for the 8-month interview continued until the close of the study to enable maximum reten-
tion. Participants who failed to attend interview appointments and who could not be reached
by telephone were visited at home by field staff if permission had been granted in advance.
Assessments were conducted in isiZulu by trained interviewers at a designated, private loca-
tion at or near the clinic where the participant was diagnosed. Referrals for ancillary/supportive
serviceswere offered after each interview, and participants were reimbursed R70, R90, and
R120 (the equivalent at the time of US $10, $12, and $15) for the baseline, 4-month, and
8-month interviews, respectively.
Measures
Except for global positioning system (GPS) distance calculations (see below), all cohort data
were obtained by self-report, as medical records in these public primary care clinics were not
created until individuals initiated ART.
Outcome. Linkage to care was defined as returning to the clinic to obtain CD4+ count test
results, a linkage indicator that has been used in other investigations [19,20]. Participants were
asked at each assessment if they had any non-hospitalization medical visits since the previous
interview, and the date, location, and reason for the visit. Based on the self-reported reasons for
visits, the interviewer determinedwhether it appeared that the participant had or had not
received his/her CD4+ count test results, and subsequently confirmed this by asking directly.
Time to linkage to care was calculated as the number of days from diagnosis to receiving CD4
+ count test results, and was converted to fractional weeks for ease of interpretation. Addition-
ally, two dichotomous outcome variables were created: (1) linkage to care by four months and
(2) linkage to care by eight months after diagnosis.
Predictor–No blood draw for CD4+ count on day of diagnosis. Not having blood drawn
for CD4+ count on the same day as receiving one’s HIV-positive test result was the predictor
of interest. At the baseline interview, we asked participants if they had a blood draw for CD4
+ count on the day of diagnosis, or if not, if they had the blood draw since then, and the date
and location of that visit. These questions were repeated at follow-up interviews for those who
had not previously reported a blood draw for CD4+ count.
Reasons for no CD4+ count blood draw. Individuals who had not had blood drawn for
CD4+ count by their baseline interviewwere asked why they had not had this test. Open-
ended responses were assigned to a priori codes, with additional codes added as needed. Codes
were grouped into clinic-related and personal reasons.
Potential confounders. These included age in years, gender, relationship status, highest
year of schooling, employment status, food insecurity, source of income, number of children
living at home, travel time to clinic, prior HIV testing, suspected beingHIV+, and number of
HIV-related symptoms, all measured prior to diagnosis. Additionally, we evaluated as potential
confounders the following psychosocial and social cognitivemeasures, also measured prior to
diagnosis: symptoms of psychological distress [18], attitudes toward returning to the clinic to
receive CD4+ results [21] (Cronbach’s alpha = 0.879), and HIV-related stigma [22] (Cron-
bach’s alpha = 0.748). Barriers to care were ascertained after diagnosis; for gender-related barri-
ers we took the mean of three items (‘your partner does not want you to go to the clinic’; ‘you
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have to take care of children or other family members’; ‘the times the clinic is open are not con-
venient for you’) (Cronbach’s alpha = 0.767).
GPS distancemeasures. At the baseline interviewparticipants identified a landmark near
their home (e.g., school, church, local shop) and estimated walking time from home to land-
mark (<10 minutes, 10–20 minutes, 21–30 minutes,>30 minutes), which we converted to
walking distances of 0.42km, 1.25km, 2.08km, 2.92km, respectively. In order to estimate travel
distance between home and clinic, we used GPS software to calculate the straight-line and by-
roads distance from the landmark to the clinic where diagnosed, and added the estimated walk-
ing distance from home to the landmark. If the participant reported having his/her blood
drawn for CD4+ count at a clinic other than where they were diagnosed, distance to that clinic
was calculated.
Statistical analyses
We compared eligible individuals who joined the cohort study versus those who did not join
using chi-squared, Student’s t-tests, or Mann-Whitney U-tests, as appropriate. Among cohort
study participants, we compared those with and without a blood draw at diagnosis with respect
to the variables described above, except for GPS distance, which was not assessed at screening.
Kaplan-Meier curves for time to linkage were plotted, and log-rank tests were used to com-
pare the cumulative probability of linkage for those with and without a day-of-diagnosis CD4
+ count blood draw, and those with clinic-related and personal reasons for no day-of-diagnosis
blood draw relative to day-of-diagnosis blood draw. Individuals were censored at their last
interview if they were lost to follow-up, died, or declined to continue with the study.
The primary analysis used Cox proportional hazards models stratified by clinic of recruit-
ment to estimate the log hazard ratio (HR) of linkage to care associated with not having CD4
+ count blood drawn on the day of diagnosis and to adjust for confounding variables.We
included in adjusted models variables that singly or in combination attenuated the crude esti-
mate by 10% or greater in order to estimate the smallest possible effect of day-of-diagnosis
blood draw. In separate models we replaced the dichotomous predictor, blood draw at diagno-
sis (no/yes), with the 3-category predictor, reason for no blood draw at diagnosis (clinic-
related, personal, had day-of-diagnosis CD4+ count blood draw). The 3-category predictor
models excluded the observations from 89 individuals who were not asked the reason for no
blood draw because they had blood drawn for CD4+ count by the time of their baseline inter-
view, and two who had missing data. To assess if the effect of day-of-diagnosis blood draw dif-
fered according to gender, we examined Coxmodels stratified by gender and tested the
significance of an interaction term between gender and day-of-diagnosis blood draw.
For the categorical outcomes (linked by four months, linked by eight months), we used
Mantel-Haenszel chi-squared statistics and conditional logistic regression, conditioning on
clinic of recruitment. Participants were included in these analyses if they had an 8-month fol-
low-up interviewor, if missing the 8-month follow-up interview, it was possible to ascertain
from baseline or 4-month interviewdata that they had a blood draw for CD4+ count by eight
months.
Results
Participant recruitment and retention
BetweenNovember 2010, and May 2012, 2967 individuals who presented for HCT at one of
the three study clinics agreed to be screened for study eligibility (Fig 1). Of these, 183 were inel-
igible (mostly because they had been diagnosed previously) and 11 did not complete the
screening interview. Of the remaining 2773, 785 (28.2%) tested HIV+, completed the post-test
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interview, and were invited to participate in the cohort study. Of those invited, 459 (58.5%)
enrolled in the study. Between the 459 eligible participants who joined the cohort study and the
326 who were eligible and did not join, the only statistically significant differences were by
clinic of recruitment (the rural clinic had higher acceptance) and relationship status (those liv-
ing with a spouse or partner had lower acceptance) (S1 Table).
Four-month interviewswere completed by 378 (82%) and 8-month interviewswere com-
pleted by 432 (94.1%) of those enrolled. Overall, 443 (96.5%) had at least one follow-up inter-
view, with a median of 39.7 person-weeks of follow-up in the entire cohort. The outcome was
able to be determined in 439 of 459 individuals (95.6%). Eight individuals lost to follow-up
after the baseline interviewwere determined to have died.
Description of the population and blood draw for CD4+ count at diagnosis
The socio-demographic characteristics of the cohort study participants overall and by day-of-
diagnosis blood draw are shown in Table 1. The median age was 29 years (IQR: 25–35), and
67% were women. The largest proportion (65%) was not cohabiting but married or in a rela-
tionship. Participants faced a number of socioeconomic challenges: one-quarter (25%) had
completed high school, less than one-third (31%) were employed, and 46% reported food inse-
curity. Sixty-one percent had not been tested previously for HIV.
Overall, 126 (27.5%) individuals had their blood drawn for CD4+ count on the same day as
receiving their HIV+ test result and 333 (72.5%) did not (Table 1). Those who had a day-of-
diagnosis blood draw were significantly older, significantlymore likely to be working and to
have an income source, lived significantly farther away from the clinic, and had a significantly
less positive attitude about returning to the clinic to obtain CD4+ count results.
Of those who did not have a day-of-diagnosis blood draw for CD4+ count, clinic-related
reasons for not having it were cited by 48.3% of the 242 who replied to this question (Table 2).
These included ‘clinic or lab was closing’ (20.7%) and ‘told by staff to return another day’
(14.0%). Personal reasons were cited by 51.7%, including ‘too shocked or upset, afraid to learn
CD4+ results’ (9.1%), ‘family or work obligations’ (9.5%), and ‘did not have time to stay’
(18.6%). No participant cited more than one reason.
Time to linkage to care by blood draw for CD4+ count at diagnosis
Of those who did not have their blood drawn on the day of diagnosis, 19.2% reported never
returning for this test and, therefore were lost to care. The Kaplan Meier curves for time to link-
age to care for those without and with a day-of-diagnosis blood draw are shown in Fig 2. The
median time to linkage was 14.71 weeks (95% confidence interval [CI]: 11.62, 17.81) for those
without a day-of-diagnosis CD4+ count blood draw and 2.86 weeks (95%CI: 1.52–4.20) for
those with this test (log-rank test p< 0.001). Kaplan-Meier curves for all three groups—those
who had a day-of-diagnosis blood draw, and those who did not because of clinic-related or per-
sonal reasons are shown in Fig 3. For those with a clinic-related reason the median time to link-
age was 14.71 weeks (95%CI: 9.54–19.89), and for those with a personal reason the median
time to linkage was 22.14 weeks (95%CI: 12.93, 31.36) (log-rank test p<0.001).
In Cox proportional hazards models, the crude hazard ratio for linkage (HRlinkage) associ-
ated with not having a day-of-diagnosis CD4+ count was 0.60 (95%CI: 0.47, 0.78) (Table 3,
upper left panel). The adjusted HR (AHRlinkage) including confounding variables (age, distance
from home to clinic by roads, participant suspected beingHIV+, and positive attitude toward
returning to the clinic to collect test results) was 0.66 (95%CI: 0.51, 0.85), indicating that the
hazard rate of linkage to care of those without a day-of-diagnosis blood draw was 34% lower
than that of those who had this test on their day-of-diagnosis.
Same-Day CD4+ Count Blood Draw and Linkage to Care
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Table 1. Description of the population at baseline, overall and by whether blood was drawn for CD4+ count on the day of diagnosis, 459 newly-
diagnosed HIV+ women and men, Durban, South Africa, 2010–2012.
ALL Blood Draw at
Diagnosis
No Blood Draw at
Diagnosis
p-value1
N = 459 N = 126 N = 333
DEMOGRAPHIC AND SOCIOECONOMIC CHARACTERISTICS
Gender, %
Women 67.3 61.9 69.4 0.159
Men 32.7 38.1 30.6
Age in years, median [Interquartile Range (IQR)] 29 [25–35] 30 [27–37] 29 [25–34] 0.043
Age group, %
< = 24 21.6 14.3 24.3 0.033
25 to 28 21.4 27.0 19.2
29 to 31 18.1 15.1 19.2
32 to 36 19.2 18.3 19.5
> = 37 19.8 25.4 17.7
Relationship status,%
Not married/in a relationship 11.1 14.3 9.9 0.230
Married/in a relationship—not living together 64.5 58.7 66.7
Married/in a relationship—living together 24.4 27.0 23.4
Number of children living with you, median [IQR] 1 [0–2] 1 [0–2] 1 [0–2] 0.229
Highest year of school,%
8th grade or less 25.1 23.8 25.5 0.569
9th-11th grade 48.6 52.4 47.1
Matriculated (completed h.s.) 16.1 12.7 17.4
More than high school 10.2 11.1 9.9
Employment, %
Employed full/part time or self-employed 30.5 38.9 27.3 0.022
Unemployed, unable to work, student 69.5 61.1 72.7
Food insecurity, %
Never 53.6 50.0 55.0 0.063
Seldom 10.5 16.7 8.1
Sometimes 23.1 22.2 23.4
Often 12.9 11.1 13.5
Income Source,%
Has income source or government grant 96.3 100.0 94.9 0.021
No income source & no government grant 3.7 0.0 5.1
Travel time to clinic, %
<1/2 hour 45.5 38.9 48.0 0.098
1/2 hour 54.5 61.1 52.0
Distance to clinic by roads km., median [IQR] 3.1 [1.7–
6.9]
3.8 [1.7–11.1] 3.0 [1.7–6.0] 0.043
TESTING CHARACTERISTICS
Ever tested (negative) before this test, %
Yes 38.6 43.7 36.7 0.212
No 61.4 56.3 63.3
Suspected HIV-positive, %
Yes/unsure 61.0 67.5 58.6 0.101
No 39.0 32.5 41.4
Number of HIV-related symptoms, %
(Continued)
Same-Day CD4+ Count Blood Draw and Linkage to Care
PLOS ONE | DOI:10.1371/journal.pone.0162085 October 5, 2016 8 / 16
A clinic-related reason for no day-of-diagnosis blood draw was associated with a crude
HRlinkage of 0.59 (95% CI: 0.43, 0.80) relative to those with a day-of-diagnosis blood draw; a
personal reason was associated with a crudeHRlinkage of 0.49 (95%CI: 0.35, 0.68) (Table 3,
lower left panel) The respective AHRlinkage for a clinic-related reason was 0.60 (95%CI: 0.44,
0.82), and for a personal reason it was 0.53 (95%CI: 0.38, 0.75), indicating that compared with
individuals who had a day-of-diagnosis blood draw, both groups not receiving a day-of-diag-
nosis blood draw had lower rates of linkage.
Table 1. (Continued)
ALL Blood Draw at
Diagnosis
No Blood Draw at
Diagnosis
p-value1
N = 459 N = 126 N = 333
None 53.2 50.0 54.4 0.530
One 20.5 23.8 19.2
More than one 26.4 26.2 26.4
PSYCHOSOCIAL and COGNITIVE FACTORS
Symptoms of psychological distress, %
Not elevated (<16) 87.7 85.5 88.5 0.473
Elevated ( 16) 12.3 14.5 11.5
HIV-related stigma, median [IQR] 2.0 [2.0–
2.0]
2.0 [2.0–2.0] 2.0 [2.0–2.0] 0.890
Gender-related barriers to care, median [IQR] 0.0 [0.0–
0.3]
0.0 [0.0–0.3] 0.0 [0.0–0.3] 0.266




4.5 [4.0–5.0] 5.0 [4.0–5.0] 0.002
1 p-value for chi-squared statistic or Mann-Whitney U test, as appropriate
doi:10.1371/journal.pone.0162085.t001
Table 2. Reasons for no CD4+ count blood draw on days of diagnosis among newly-diagnosed HIV
+ women and men, Durban South Africa, 2010–2012.
N % Category %
Clinic-related Reasons
Clinic or lab too full 8 3.3%
Too late—Clinic or lab closed/closing 50 20.7%
Told by staff to return another day 34 14.0%
Unsure of what to do next or not told to get CD4+ count 18 7.4%
Did not have correct clinic documents 7 2.9% 48.3%
Personal Reasons
Too shocked or upset, or afraid to learn CD4+ results 22 9.1%
Prefer CD4+ testing at a different clinic 5 2.1%
Prefer to return another day 18 7.4%
Family or work obligations (no one to care for people at home, unable to
take time from work)
23 9.5%
Did not have time to stay 45 18.6%
Other (felt too ill, wanted someone to accompany them, personal problem) 12 5.0% 51.7%
Total 242 100.0%
Note: 89 of the 333 who did not have blood drawn at diagnosis were not asked this question, as their blood
draw had been completed by the time of their baseline interview, and 2 responses were missing.
doi:10.1371/journal.pone.0162085.t002
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The dichotomous outcomes also are shown in Table 3 (center and right columns). By four
months after diagnosis, 54.8% of those without a day-of-diagnosis CD4+ count blood draw
versus 75.2% of those with one were linked to care (M-H chi-squared p = 0.004). By eight
months, 71.7% of those without a day-of-diagnosis blood draw vs. 83.2% of those with were
linked to care (M-H chi-squared p = 0.220). The respective adjusted odds ratio for linkage by
four months (AOR4mo.linkage) was 0.52 (95%CI:0.32, 0.87) and by eight months, AOR8mo.linkage
was 0.76 (95%CI:0.42, 1.37).
Considering reasons for no day-of-diagnosis blood draw, AOR4mo.linkage for a clinic-related
reason was 0.48 (95%CI: 0.26, 0.88) and AOR4mo.linkage for a personal reason was 0.37 (95%CI:
0.20, 0.68) relative to those who had this test on the day-of-diagnosis. By eight months, the
odds of linkage were lower for both clinic-related and personal reasons but no longer signifi-
cantly different from those with a day-of-diagnosis blood draw (AOR8mo.linkage for clinic-
related reasons = 0.76; 95%CI: 0.38, 1.52; AOR8mo.linkage for personal reasons = 0.51; 95%CI
0.26, 1.01).
In analyses stratified by gender (not shown in table), the AHRlinkage for day-of-diagnosis
blood draw among women was 0.70 (95%CI: 0.52, 0.95, p = 0.025); among men, it was 0.51
(95%CI: 0.30, 0.86, p = 0.012). Thus, the effect was significant among both groups, and the
interaction term was not significant (p = 0.54). The pattern was similar when the predictor was
Fig 2. Time to linkage to care by CD4+ count blood draw at diagnosis, newly-diagnosed HIV+ South African
women and men.
doi:10.1371/journal.pone.0162085.g002
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‘reason for no blood draw’. Compared with day-of-diagnosis blood draw, clinic-related and
personal reasons were significantly associated with lower rates of linkage among both women
and men [Women: AHRlinkage for clinic-related reasons = 0.69 (95%CI: 0.47, 1.01, p = 0.054)
and AHRlinkage for personal reasons = 0.58 (95%CI: 0.39, 0.86, p = 0.006); Men: AHRlinkage for
clinic-related reasons = 0.40 (95% CI: 0.21, 0.75, p = 0.005) and AHRlinkage for personal rea-
sons = 0.25 (95% CI: 0.11, 0.58, p = .001).] The p-value associated with the interaction term
was 0.40.
Discussion
In this prospective study that identified individuals prior to HCT and followed them for eight
months from the day of diagnosis with high retention rates, we found that newly-diagnosed
HIV+ individuals who did not have their blood drawn for CD4+ count on the same day as they
were diagnosed had a significantly lower rate of linkage to care than those who did, and that
both clinic-related and personal reasons for not having this test on the day of diagnosis were
associated with a significantly lower rate of linkage. The effects were similar for women and
men. Moreover, almost one-fifth of those who did not have this test done on their day of diag-
nosis never returned.
Fig 3. Time to linkage to care by CD4+ count blood draw at diagnosis and reason for no blood draw, newly-
diagnosed HIV+ South African women and men.
doi:10.1371/journal.pone.0162085.g003
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There are three important implications of these findings. First, this study highlights the
importance of identifying very early losses to care. Regardless of the reason, leaving the clinic
without completing all the recommended services for that visit seemed to be a marker for being
at risk for delayed or no return. Tracking HIV+ individuals enrolled in care—both pre-ART
and after initiating ART—for potential loss to follow-up is now an accepted best practice [23],
and our study demonstrates that this practice needs to be conducted from the point of diagno-
sis, even if ART is initiated early in care.
Table 3. Linkage to care by day-of-diagnosis blood draw for CD4+ count and reasons for no day-of-diagnosis blood draw, newly-diagnosed HIV
+ women and men, Durban, South Africa, 2010–2012.
Hazard Ratio of Linkage1 Percent Linked to Care Odds Ratio of Linkage by
4 months5
Odds Ratio of Linkage by
8 months5
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1Estimated from a Cox proportional hazards model.
2 N = 453; 6 participants were missing data on distance to clinic.
3Adjusted for age in years, distance to clinic, suspected being HIV, attitude for returning to clinic for CD4+ results. Note that besides blood draw at
diagnosis, only age was significantly associated with linkage to care in the adjusted models.
4 N = 439; 20 participants were missing data on linkage to care
5 Estimated from a conditional logistic regression model.
6N = 433, 20 participants were missing data on linkage to care and 6 were missing data on distance to clinic.
7N = 368, 91 participants were missing data: 89 were not asked this question because they had a blood draw for CD4+ count by the baseline interview, and
2 were missing responses.
8 N = 362, 6 participants were missing data on distance to clinic.
9 N = 354 participants; 20 participants were missing data on linkage to care.
10 N = 348 participants; 20 participants were missing data on linkage to care and 6 were missing data on distance to clinic.
* Mantel-Haenszel chi-squared statistic could not be calculated.
doi:10.1371/journal.pone.0162085.t003
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Second, clinic-related barriers were important in explaining about half of the cases with no
day-of-diagnosis blood draw. Clinic procedures can make a difference in individuals’ ability to
complete necessary services, especially in settings where poverty-related barriers may make it
difficult to attend the clinic. Once identified, clinic-related barriers often can be addressed
through changes in procedures.
In this study 35% of individuals who did not have blood for CD4+ count drawn at diagnosis
indicated that the clinic or lab was closing, or that they were told by staff to return another day.
When we presented study findings to clinic staff, they explained that CD4+ blood draws were
sometimes deferred because the van collecting specimens for transport to the laboratory had
already left on that day, and bloodwas not stored in the clinic overnight. However, new evi-
dence suggests this barrier could be eliminated without great expense; Skhosana et al. demon-
strated high reproducibility of CD4+ count results of blood refrigerated overnight [24]. If those
findings are replicated, arriving ‘late in the day’ would no longer be a barrier for individuals to
have an immediate blood draw for CD4+ count.
Third, personal reasons for leaving the clinic before having blood drawn for CD4+ count
also were important, and these require further investigation, both in research and in practice.
Although some explanations lacked detail, they likely reflect psychological processes related to
receiving a diagnosis of a life-threatening and highly stigmatized disease, along with structural
barriers related to work and family responsibilities. Such barriers may continue to exert an
influence even if disease-stagingprior to initiation ART is eliminated. Therefore, our findings
also highlight how vital it is to ensure that newly-diagnosedHIV+ individual leave the clinic
with a basic package of linkage services–immediatepsychological support, an assessment of
barriers to returning to the clinic, and a plan for follow-up contact and support. These services
often are not routine in busy public sector clinics such as those where we conducted this study,
but are essential to successful linkage to care.
The findings of this study also are notable for their consistency across women and men.
Whereas other research has shown that men are at greater risk than women for late diagnosis
and loss to care [5,20], the effects of having a day-of-diagnosis blood draw (and of not doing so
for clinic-related and personal reasons) did not differ significantly betweenwomen and men.
Strengths of this study include that it was a prospective cohort study representative of peo-
ple undergoing HCT at these clinics, with close to a 60% of those eligible joining the study.
Minimal differences between eligible participants who joined and did not join—by clinic and
relationship status—were unlikely to have altered these findings, as all analyses were stratified
by clinic, and relationship status was not associated with the exposure or outcome. Additional
strengths included that we identified potential study participants and assessed potentially con-
founding variables prior to diagnosis, had less than 4% loss to follow-up, and that we obtained
detailed information about dates, locations, and reasons for all clinic visits during the follow-
up period. A limitation was that we relied on participant self-report of clinic visits and tests,
including both the exposure and outcome. In these public primary care clinics individual medi-
cal records were not created until an HIV+ person initiated ART. Although dates of blood
draw could have been obtained from the National HIV laboratory system, we did not use this
source because it lacked data on our primary outcome–return to the clinic to obtain CD4+
count test results. Due to the careful way that we elicited visit data, we believe they were compa-
rable in completeness and accuracy to what we would have obtained through clinical records
had they existed. However, having multiple sources from which to obtain and validate this
information would have increased accuracy.
Other limitations are that we did not probe individuals’ explanations for why they did not
have a day-of-diagnosis blood drawn for CD4+ count and we did not ask this question of peo-
ple who had had this test done by the time of their baseline interview. Additionally, although
Same-Day CD4+ Count Blood Draw and Linkage to Care
PLOS ONE | DOI:10.1371/journal.pone.0162085 October 5, 2016 13 / 16
we did not provide clinic visit reminders, payments to individuals when they returned for
study interviews (which were conducted close to clinics of recruitment)may have encouraged
them to keep clinic visits. Our estimates of time to linkage, therefore, may be higher than what
would have occurredwithout the study.
In summary, in a detailed analysis made possible by interviewing individuals beginning
when they first presented for HCT, we have shown that adherence to the South African health
service guideline for immediate blood draw for CD4+ count on the day of diagnosis was less
than optimal in these clinics, and was associated with substantial loss to follow-up and delayed
linkage to care. Engaging clinic staff in identifying and removing clinic-related barriers to these
first steps in care can be an important tool for achieving the 90-90-90 targets set forth by
UNAIDS [25]. Further exploration of the personal reasons that newly-diagnosed individuals
reported for leaving the place of diagnosis without completing all procedures could help iden-
tify better approaches for providing support at this critical stage.
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